Patients younger than forty years old with hepatitis C virus genotype–1 chronic infection had treatment responses similar to genotype–2 infection and not related to interleukin–28B polymorphism
Background and rationale. Age is one of the predictors for sustained virological response (SVR) when treating chronic hepatitis C (CHC) patients with pegylated-interferon/ribavirin (PegIFN/RBV). However, the treatment responses of the young patients had not been analyzed before. Therefore, we conduc...
Main Authors: | Chun-Yen Lin, M.D. Ph.D., I-Shyan Sheen, Wen-Juei Jeng, Chang-Wen Huang, Chien-Hao Huang, Ji-Yih Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119313869 |
Similar Items
-
Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01) -
Interleukin-28B (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus
by: Hamid Kalantari, et al.
Published: (2014-01-01) -
Prevalence of interleukin-28B single nucleotide polymorphism genotypes in patients with hepatitis C infection in Isfahan, Iran
by: Mohammad Minakari, et al.
Published: (2016-01-01) -
Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin
by: Ezequiel Ridruejo, et al.
Published: (2011-10-01) -
The role of biochemical variations and genotype testing in determining the virological response of patients infected with hepatitis C virus
by: Abid Shoukat, et al.
Published: (2018-01-01)